person
Bastian V. T.
- Country
- Germany
- Department
- Klinik für Hämatologie und Stammzelltransplantation
Research Overview
assignment
37
Clinical Trials ·
- A Randomized, Open-label, Phase 3 Study of Acalabrutinib in Combination with Rituximab and Reduced Dose CHOP (R-miniCHOP) in Older Adults with Untreated Diffuse Large B-Cell Lymphoma (ARCHED/GLA 2022-1)
- Phase II Study of Glofitamab-Based Induction Followed by CAR‑T Cell Therapy in High‑Risk Relapsed/Refractory Large B‑Cell Lymphoma
- AZD0120 Versus Standard Regimens in Relapsed or Refractory Multiple Myeloma: A Phase III Randomised Study
location_city
3
Research Sites
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
204
Sites with multiple studies
Has run more than one trial at 204 of 378 partner sites.
Specializations
Lymphoma Research
Specializes in innovative treatments for various forms of B-cell lymphomas, with particular emphasis on diffuse large B-cell lymphoma (DLBCL) and mantle cell lymphoma.
- CAR-T cell therapies for lymphoma
- Novel antibody-drug combinations
- Central nervous system lymphoma treatments
Leukemia Studies
Focuses on developing treatments for acute myeloid leukemia and chronic lymphocytic leukemia, particularly investigating targeted therapies.
- FLT3 mutation targeted treatments
- Venetoclax-based combination therapies
- Novel therapeutic approaches for relapsed/refractory disease
Multiple Myeloma Investigations
Conducts research on multiple myeloma treatments, with emphasis on innovative cellular therapies and maintenance strategies.
- Autologous stem cell transplantation outcomes
- CAR-T cell therapy applications
- Novel therapeutic combinations for relapsed disease
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.